key: cord-0806333-ksgufztd
authors: Morris, Gerwyn; Bortolasci, Chiara C.; Puri, Basant K.; Olive, Lisa; Marx, Wolfgang; O'Neil, Adrienne; Athan, Eugene; Carvalho, Andre; Maes, Michael; Walder, Ken; Berk, Michael
title: Preventing the development of severe CoVID 19 by modifying immunothrombosis
date: 2020-10-20
journal: Life Sci
DOI: 10.1016/j.lfs.2020.118617
sha: d513aa321db04fde9a50aa1fcd7ac140a79baebe
doc_id: 806333
cord_uid: ksgufztd

BACKGROUND: COVID-19-associated acute respiratory distress syndrome (ARDS) is associated with significant morbidity and high levels of mortality. This paper describes the processes involved in the pathophysiology of COVID-19 from the initial infection and subsequent destruction of type II alveolar epithelial cells by SARS-CoV-2 and culminating in the development of ARDS. MAIN BODY: The activation of alveolar cells and alveolar macrophages leads to the release of large quantities of proinflammatory cytokines and chemokines and their translocation into the pulmonary vasculature. The presence of these inflammatory mediators in the vascular compartment leads to the activation of vascular endothelial cells platelets and neutrophils and the subsequent formation of platelet neutrophil complexes. These complexes in concert with activated endothelial cells interact to create a state of immunothrombosis. The consequence of immunothrombosis include hypercoagulation, accelerating inflammation, fibrin deposition, migration of NET producing neutrophils into the alveolar apace, activation of the NLRP3 inflammazome, increased alveolar macrophage destruction and massive tissue damage by pyroptosis and necroptosis Therapeutic combinations aimed at ameliorating immunothrombosis and preventing the development of severe COVID19 are discussed in detail.

presence of hypercytokinemia in the lungs (Liao et al., 2020 , Mehta et al. , 2020 , Zhang et al. , 2020b and in the periphery (Liao et al., 2020 , Qin et al., 2020 , Shi et al. , 2020b , Zhang et al. , 2020c of patients with severe COVID-19 is another replicated finding. The pattern and intensity of cytokine and chemokine abnormalities is characteristic of cytokine release syndrome and a "cytokine storm" and many authors have suggested that this illness may be viewed as a virally induced sepsis , Mehta et al., 2020 , Moore and June, 2020 , Qin et al., 2020 , Ye et al. , 2020 .

To date the pathophysiology of COVID-19 ARDS has not been proposed and treatment options are limited. Accordingly, this paper proposes a model of the illness based on the observations cited above and extensive research into ARDS secondary to sepsis and or severe viral infections and discusses potential treatments targeting the proposed drivers of pathology.

There is accumulating evidence that SARS-CoV-2 infects and activates type 2 alveolar epithelial cells resulting in the development of endoplasmic reticulum stress, NLP3 inflammasome activation and in many cases the death of these cells by apoptosis and pyroptosis (Fox et al., 2020 , Mason, 2020 , Tian et al., 2020 , Yang, 2020 , Yao et al. , 2020a , Yao et al., 2020b . Moreover, the weight of evidence suggests that SARS-6 Sauler et al. , 2019 , Ueno et al. , 2004 . This association is due in part to the release of high mobility group box 1 (HMBG1) and other inflammatory DAMPS directly contributing to an escalating pattern of tissue damage (Faust and Mangalmurti, 2020 , Sauler et al., 2019 , Ueno et al., 2004 .

The activation of AMs leads to their polarisation into a proinflammatory "M1" phenotype secreting high levels of proinflammatory cytokines (PICs) and chemokines such as TNF-alpha IL-1 beta, IL-6, and IL-8 (Aberdein et al. , 2013 , Losa García et al. , 1999 .

Crucially ,the subsequent release of these inflammatory mediators into the pulmonary vasculature plays an indispensable role in the development of ARDS by initiating a series of events which results in the activation of vascular endothelial cells (Frantzeskaki et al. , 2017 , Han and Mallampalli, 2015 , Huang et al. , 2018 , platelets (El Haouari, 2019 , Freedman, 2008 , Violi et al. , 2010 , neutrophils (Øynebråten et al. , 2015, Sonmez and Sonmez, 2017) , ultimately resulting in the formation of platelet neutrophil complexes at the surface of the endothelium (Finsterbusch et al. , 2018 , Sreeramkumar et al. , 2014 , Stark, 2019 . The formation of these complexes encourages and enables the recruitment of highly cytotoxic neutrophils and inflammatory activated platelets into the alveolar space and pulmonary intestinal resulting in a host of pathogenic consequences, as discussed below (Frantzeskaki et al., 2017 , Han and Mallampalli, 2015 , Huang et al., 2018 .

One such consequence is the development of a highly inflammatory and pro-coagulant state typified by hyperactivation of the coagulation cascade and relative exhaustion of the fibrinolytic system with excessive production of PICs, DAMPS and fibrin deposition (Engelmann and Massberg, 2013 , Frantzeskaki et al., 2017 , Kimball et al. , 2016 . This is described as immuno-thrombosis (Engelmann and Massberg, 2013, Frantzeskaki et al., J o u r n a l P r e -p r o o f Journal Pre-proof 2017 , Kimball et al., 2016 . This state has a major pathophysiological role in the development and exacerbation of systemic sepsis as it generates the formation of vascular microthrombi, and is responsible the development of DIC and subsequent multi-organ damage or failure (Assinger et al. , 2019 , Dewitte et al. , 2017 , Nedeva et al. , 2019 .

The sequestration of platelet neutrophil complexes in the pulmonary vasculature and the subsequent development of immunothrombosis is also the ultimate cause of micro-thrombi and micro-emboli in the alveocapilary circulation (Lim et al. , 2013 , Pfeiler et al. , 2014 , intra alveolar fibrin deposits (Frantzeskaki et al., 2017 , Prabhakaran et al. , 2003 , Sapru et al. , 2010 , Xue et al. , 2015 , Yadav and Kor, 2015 and in some circumstances the development of DIC. Readers interested in further details are referred to (Gando and Otomo, 2015, Ito, 2014) . The translocation of NET producing neutrophils into alveoli and interstitial lung tissue also plays a dominant role in the development of an intrapulmonary cytokine storm ultimately leading to the massive levels of lung tissue damage characteristic of COVID-19 ARDS.

In the context of ARDS accumulating data suggests that the self-amplifying cascade of PIC ROS and DAMP production leads to the activation of the NLRP3 inflammasome and the release of IL-1 and IL-18 (Long et al. , 2020 . This is increasingly considered to be an irrevocable step in the development of ARDS and high levels of NLRP3 inflammasome activity associated with a grave prognosis (Dolinay et al. , 2012 , Grailer et al. , 2014 , Makabe et al. , 2012 . It is however encouraging to note that the inhibition of NLRP3 assembly is associated with increased rates of survival (Jin et al. , 2017 , Kim et al. , 2016 (reviewed by (Danielski et al. , 2020) ). reduction in Zn levels is predictive of increased mortality and the extent of reduction correlates negatively with levels of inflammation, increased severity of symptoms and damage to the heart and other organs (Alker and Haase, 2018 , Besecker et al., 2011 , Knoell and Liu, 2010 . Due to this, Zn levels have been suggested as a diagnostic marker of SIRS/sepsis and likelihood of mortality (Alker and Haase, 2018) .

Mechanistically, evidence suggests that this state of affairs seen in an environment of excessive systemic inflammation, stems from increased activity and levels of ZIP-14 and ZIP-8, two promiscuous members of the SLC-39A family of Zn transporters, which stimulate the uptake of Zn from the plasma into the liver (Aydemir and Cousins, 2018 , Lichten et al. , 2009 , Liuzzi et al. , 2005 . This phenomenon, commonly observed in a state of excessive inflammation, is driven by elevated levels of IL-6, lipopolysaccharide (LPS), IL-1 and nitric oxide (NO) which increase the activity of the transcription factors AP-1 and ATF-4, resulting in increased uptake of Zn into the liver resulting in state of hypozincaemia (Aydemir and Cousins, 2018 , Lichten et al., 2009 , Liuzzi et al., 2005 . Importantly, grossly reduced levels of plasma Zn results in a compromised and dysfunctional response to pathogen invasion by the innate and humoral branches of the immune system (Fraker and King, 2004 , Kogan et al. , 2017 , Prasad, 2007 . Typically, and perhaps paradoxically, the results of depleted Zn influenced immune dysfunction in sepsis patients (Cirino Ruocco et al., 2018) manifests as an exacerbated inflammatory response associated with increased activity of NF-κB, excessive levels of PIC production, oxidative damage to tissues and massive levels of leucocyte death (Abraham, 2005 , Besecker et al., 2011 , Hotchkiss and Nicholson, 2006 , Jarosz et al. , 2017 . From a pathophysiological perspective, it is important to note that these factors seen in patients in the early stages of SIRS and J o u r n a l P r e -p r o o f Journal Pre-proof sepsis development appear to be associated with significant increases in mortality (Abraham, 2005, Knoell and Liu, 2010) .

Data also suggests that another important factor associated with increased mortality in sepsis patients is elevated levels of NF-κB activity, most notably in the lungs (Abraham, 2005 , Bao et al. , 2010 . In this context, it is encouraging to note that Zn supplementation may reduce NF-κB activity in vivo either directly or by inhibiting the STAT-3-NF-κB signalling pathway (Bao et al., 2010 , Knoell and Liu, 2010 , Liu et al. , 2014 . Data from animal studies also suggests that Zn supplementation may restore immune homeostasis in patients experiencing severe systemic inflammation and inhibit the development of sepsis and ARDS (Souffriau and Libert, 2018, Wessels and Cousins, 2015) .

The importance of Zn deficiency in the development of ARDS has also been emphasised by the results of a recent paper that reported reduced levels of this ion in intensive care unit patients who went on to develop ARDS compared to those who did not (Boudreault et al. , 2017) . Moreover, these authors concluded that low levels of Zn predisposed to ventilator induced lung injury (Boudreault et al., 2017) .

Finally, from the perspective of immune modulation, there is some evidence to suggest that Zn deficiency may exacerbate NLRP3 activity and increase levels of IL-1 beta (Fan et al. , 2017 , Summersgill et al. , 2014 .The mechanism underpinning this phenomenon is not completely understood but increased lysosomal permeability in a cellular environment of chronic Zn deficiency may be a contributing factor (Summersgill et al., 2014) . Zn is also one of the few supplements with credible evidence of anti-viral actions and given the paucity of such candidates we focus on this area below.

There is evidence that high levels of Zn salts may inhibit the essential RNA dependent RNA polymerase (RdRp) enzyme, which is conserved in all coronaviruses (te Velthuis et al. , 2010 ). It appears that this property may extend to the respiratory syncytial virus (RSV), rhinoviruses, hepatitis E, dengue, West Nile and Zika viruses whose RdRp is almost identical to the equivalent enzyme in coronaviruses (Hodge et al. , 2016 , Kar et al. , 2019 , Kaushik et al. , 2017 , Suara and Crowe, 2004 . The inhibitory influence of excess Zn appears to the fact that these RdRp are in effect protein metallothionines dependent on an intricate quantum relationship between bound Zn and magnesium for their activity. This relationship appears to be disturbed in a cellular environment of excess Zn ions (Godoy et al. , 2017 , Potapova et al. , 2016 . In vitro evidence suggesting that Zn chelation may inhibit the RNA dependent RNA polymerase of COVID-19, effectively halting the replication of the virus, has understandably stimulated a great deal of interest in Zn supplementation as a means of inhibiting the replication of COVID-19 in vivo (te Velthuis et al., 2010) .

There is a large and accumulating body of evidence demonstrating significant improvements in patients suffering from a range of serious lung diseases following the long term administration of azithromycin (AZM) and other macrolide antibiotics (reviewed by (Faverio et al. , 2017) ). Importantly, in the case of AZM, such evidence extends to reducing mortality in patients suffering from ARDS secondary to a range of insults or sepsis (Kawamura et al. , 2018 , Kawamura et al. , 2016 . For example, Kawamura and others (2018) engaged in a retrospective review of outcomes in 191 ARDS patients and reported a statistically significant improvement in the 60 days survival of patients prescribed AZM compared to those on standard care only. This was also accompanied by reduced time on ventilation J o u r n a l P r e -p r o o f (Kawamura et al., 2018) . The results of this study echoed earlier work by this team of authors with almost identical outcomes in patients with ARDS induced by sepsis (Kawamura et al., 2016) . Importantly, significant reductions in mortality following AZM therapy has also been reported in patients suffering from acute lung injury (Walkey and Wiener, 2012) . In addition, a large meta-analysis of prospective studies involving over 70,000 elderly patients hospitalised with pneumonia also reported a significant improvement in mortality in these individuals prescribed AZM compared to those who had not been given this medicine on admission to hospital (Mortensen et al. , 2014) .

There is a growing appreciation that the benefits accrued by patients following the administration of AZM and other macrolide antibiotics is due to their pleiotropic immunomodulatory properties. A recent meta-analysis concluded that over time the administration of these molecules resulted in reduced levels of chemokines, most notably IL-8, decreasing molecular adhesion (E-selectin, ICAM-1), integrins (CD11b/CD18), reduced levels of PICs, inhibition of neutrophil and eosinophil function, decreased effector T cell activity and reduced levels of matrix metalloproteinase 9 (Zimmermann et al. , 2018) .

From the perspective of a potential treatment for ARDS, it should be noted that AZM accumulates in alveolar macrophages and neutrophils to a far greater degree than any other macrolide and levels of the antibiotic within these immune cells may be 2000 times greater than levels found in the plasma following short term or long term administration (Gualdoni et al. , 2015 , Idris et al. , 2009 . This is of importance as evidence suggests that AZM is a highly effective NF-κB inhibitor in vivo (Aghai et al. , 2007 , Stellari et al. , 2014 . Hence, AZM offers an option to inhibit NF-κB in a highly targeted manner.

Several human and animal studies have also reported a profound change in the polarisation of activated alveolar macrophages from the highly inflammatory M1 phenotype to the antiinflammatory M2 phenotype following prolonged treatment with AZM for a range of pulmonary and autoimmune illnesses (Cory et al. , 2014 , Feola et al. , 2010 , Haydar et al. , 2019 , Murphy et al. , 2008 , Wang et al. , 2018b . These changes are characterised by significant changes in the transcriptome of AMs as evidenced by the upregulation of CCL18, fibronectin, arginase 1 and a decrease in the production of Matrix metallopeptidase 9 (MMP-9), inducible nitric oxide synthase 2 (NOS2) and PICs due to the inhibition of STAT-1 and reduced translocation of NF-κB (Cory et al., 2014 , Feola et al., 2010 , Haydar et al., 2019 . Ultimately, the positive effects of AZM on AM polarisation appears to be via the stimulation of PI3/Akt/mTor signalling, which inhibits the activity of NF-κB and stimulates the expression of genes involved in the transition between the inflammatory and antiinflammatory phenotypes (Bai et al. , 2009 , Hussain et al. , 2012 , Linton et al. , 2019 , Wang et al., 2018b , Xuejiao et al. , 2019 . The activation of the phosphoinositide 3-kinase (PI3K) signalling pathway is also associated with increased AM efferocytosis (Sharif et al. , 2019) , and reports of improved AM phagocytosis following AZM therapy are unsurprising (Hodge et al. , 2006 , Hodge et al. , 2008 , Hodge and Reynolds, 2012 .

AZM also appears to induce the recruitment of CD11b + Gr-1 + myeloid-derived suppressor cells (MDSC) into the lung (Feola et al., 2010) and this seems to be a general property of macrolides (Namkoong et al. , 2018) . This is important, as MDSCs are potent suppressors of T cell responses and evidence suggests that they play an important role in ameliorating damage to lung tissue following severe pneumonia or the advent of septic shock (Hochst et al. , 2015 , Namkoong et al., 2018 (reviewed by (Alshetaiwi et al. , 2020) ). The combined J o u r n a l P r e -p r o o f effects of AZM on AMs and MDSCs go some distance to explaining the reduction in lung tissue damage and inflammation reported following chronic administration of this antibiotic (Crosbie and Woodhead, 2009 , Shinkai and Rubin, 2005 , Suresh Babu et al. , 2013 , Vanaudenaerde et al. , 2007 , Yamada et al. , 2000 .

In addition, there is ample evidence to suggest that chronic AZM therapy results in reduced neutrophil infiltration into the lungs and ameliorates pre-existing neutrophilia (Luu et al. , 2012 , Piacentini et al. , 2007 , Tsai et al. , 2004 , Verleden et al. , 2006 ). This appears to be largely due to decreased IL-8 production by alveolar macrophages and epithelial cells, although there is some suggestion that decreased IL-8 production by alveolar myofibroblasts may also be involved (Shinkai et al. , 2006 , Vanaudenaerde et al., 2007 , Verleden et al., 2006 , Yamada et al., 2000 .

Prolonged AZM treatment also has profound effects on neutrophil function and survival leading to significant and large decreases in PIC production and survival (Koch, 2000 , Legssyer et al. , 2006 , Parnham et al. , 2005 , Silvestri et al. , 1995 .The anti-inflammatory effect of AZM on neutrophil performance appears to be mainly mediated by PI3K mediated inhibition of NF-kB in a similar manner to the anti-inflammatory effects on AMs. In some respects, this can also be said of increased neutrophil apoptosis as a result of decreased levels of IL-6 and IL-8, which would otherwise increase neutrophil survival. However, decreased neutrophil survival following AZM administration also appears to be mediated by the inhibition of GM-CSF (Castellani et al. , 2019 , Yamasawa et al. , 2004 . This cytokine regulates many aspects of neutrophil function and decreased levels inhibit neutrophil priming, which is important in the development of ARDS (Castellani et al., 2019) . In addition GM-CSF downregulation appears to be responsible for the neutrophil recognition of J o u r n a l P r e -p r o o f chemotactic stimuli, which is important in reducing the recruitment of activated neutrophils into inflamed lung tissue (Idris et al., 2009) . The downregulation of this cytokine is also an important therapeutic benefit as there is evidence that elevated levels of GM-CSF is a major contributor to extensive lung damage and increased mortality in severe pneumonia (Choi et al. , 2008 , Puljic et al. , 2007 .

Finally, there is evidence to suggest that AZM inhibits the activity of the NLRP3 inflammasome and the subsequent release of IL-1 beta (Gualdoni et al., 2015 , Lendermon et al. , 2017 . Moreover, there is evidence that AZM decreases the stability of NLRP3 mRNA likely via a direct effect on ribosomes (Lendermon et al., 2017) which is a different mechanism than in the case of Zn suggesting that the use of Zn and AZM in combination might produce additive or synergistic results.

Three recent meta-analyses have reported significantly increased survival in ARDS patients prescribed aspirin compared to those who were aspirin free (Du et al. , 2018 , Wang et al. , 2016 , Wang et al. , 2018c . Furthermore, the effect appear to be greater in critically ill patients and patients with ARDS-related sepsis than a wider group of patients (Du et al., 2018 , Wang et al., 2016 . Pertinently, there is also data to suggest that aspirin prophylaxis might also reduce the severity of ARDS and result in a substantial reduction in long term mortality (reviewed by (Wang et al., 2018c) ).

Several research teams have also reported reduced mortality in patients over 65 presenting at hospital with severe pneumonia prescribed aspirin compared to those who were aspirin naive (Falcone et al. , 2015 , Winning et al. , 2010 , Winning et al. , 2009 . For example, Falcone et al reported a four-fold reduction in mortality in aspirin treated patients suffering J o u r n a l P r e -p r o o f from severe pneumonia compared to controls (Falcone et al., 2015) . Importantly, this was a large study containing 390 patients in the aspirin arm and 614 aspirin free (Falcone et al., 2015) . Similar results have been provided from earlier studies where patients ingesting aspirin in the community or administered the drug at the point of hospital admission demonstrated significantly reduced mortality especially in patients with severe symptoms and or those who became critically ill (Winning et al., 2010 , Winning et al., 2009 . Given that aspirin use in the community may be associated with greater health literacy and other adaptive health behaviours, these confounders may need to be borne in mind.

The presence of activated platelets in patients suffering from viral pneumonia or a severe upper respiratory tract infection is a well-documented (Cangemi et al. , 2014 , Kreutz et al. , 2007 , Méndez et al. , 2018 . In addition, platelet activation is associated with a higher risk of myocardial infarction and cardiovascular related mortality seen in this group of patients (Cangemi et al., 2014 , Violi et al. , 2017 . Hence it seems reasonable to suggest that at least some of the potential benefits of aspirin to this group of patients may be mediated by the anti-platelet effects of aspirin. These are generally attributed to the irreversible acetylation of cyclooxygenase (COX) 1 and the long-term inhibition of thromboxane A2 (Antithrombotic Trialists et al. , 2009) .

Aspirin also exerts a range of beneficial effects on the coagulation cascade and the prevention of thrombosis in addition to inhibiting COX1 (reviewed by (Patrono, 2015) ).

Several mechanisms appear to be involved including reducing tissue factor production by platelets and immune cells with the acetylation of thrombin and prothrombin also playing an important role (Undas et al. , 2007) (reviewed by (Undas et al. , 2014) ). In addition, high dose aspirin (greater than 300mg/day) appears to increase the efficiency of fibrinolysis J o u r n a l P r e -p r o o f (Bailey et al. , 2015 , Tehrani et al. , 2012 . Ingestion of aspirin also leads to the upregulation of lipoxin A4 in humans and animals (Chiang et al. , 2004 , Goicoechea et al. , 2017 , Morris et al. , 2009 via a mechanism involving the irreversible acetylation of COX2 (Chiang et al. , 2005 , Colby et al. , 2018 (reviewed by (Romano et al. , 2015) ). This is an important consequence of aspirin as these molecules play major role in the resolution of inflammation in conditions such as sepsis and ARDS (Toner et al. , 2015, Yadav and Kor, 2015) . Importantly, aspirin is the only nonsteroidal anti-inflammatory drug capable of activating lipoxins in immune, endothelial and epithelial cells and the only trigger of lipoxin A4 production by platelets (Colby et al., 2018) .

The role of lipoxin A4 in the resolution of acute lung damage and ARDS are multiple. For example, it is involved in the repair of pulmonary epithelium by stimulating the transdifferentiation of alveolar type 2 cells into alveolar type 1 cells and the recruitment of the former from distal tissue (Mishra et al. , 2019 , Zheng et al. , 2016 (reviewed by (Chandrasekharan and Sharma-Walia, 2015) ). In addition, the upregulation of this molecule in neutrophils and macrophages also reduces the activity migration priming of the former and the efficiency of phagocytosis and activity of the latter (Potey et al. , 2019 , Zheng et al., 2016 . Upregulation of lipoxin A4 also induces a wide range of anti-inflammatory effects stemming from reductions in TNF-alpha , increased SOCS2 (Machado et al. , 2006) , decreased translocation of HGMB1 and inhibition of NF-κB , Sham et al. , 2018 , Wang et al. , 2014 .

Finally, there is evidence that aspirin administration inhibits the activation of the NLP3 inflammasome (Bleda et al. , 2015 , De Haro et al. , 2019 , El-Kharashi et al. , 2018 . In addition, this may be a specific property of aspirin and may underpin a significant J o u r n a l P r e -p r o o f improvement in endothelial function (Bleda et al., 2015 , El-Kharashi et al., 2018 . This data raises questions regarding the appropriate dose of aspirin for consideration in a trial of a treatment for COVID-19. In particular, 75mg /day would appear to have little or no effect on COX2 inhibition, and significant NF-κB inhibition would appear to require doses in excess of 300 mg per day and would seem to be optimal at 1500mg per day (Liao et al. , 2015 , Ornelas et al. , 2017 . It is possible that the doses of aspirin required may rival those used in the treatment of rheumatic fever (Ralph et al. , 2017) .

Oral and intravenous NAC administration has demonstrated clinical efficacy in patients suffering from a wide range of chronic refractory respiratory illnesses including chronic bronchitis (Grandjean et al. , 2000 , Reichenberger and Tamm, 2002 , Stey et al. , 2000 , chronic obstructive pulmonary disease (Dekhuijzen and van Beurden, 2006 , Pirabbasi et al. , 2016 , Sanguinetti, 2016 , Shen et al. , 2013 , cystic fibrosis, bacterial biofilms (Olofsson et al. , 2003) , asthma, pulmonary fibrosis and allergies (Conrad et al. , 2015 , Feng et al. , 2019 , Tirouvanziam et al. , 2006 . There has also been interest in NAC as a treatment for ARDS and two recent meta analyses concluded that NAC reduced the need for ventilation and shortened ventilation time, although no reductions in mortality have been reported (Lu et al. , 2019 . However, a reduction in the need for ventilation is a major therapeutic benefit as ARDS patients may suffer long term physical and psychological morbidity which are associated with significant health care costs (Rubenfeld and Herridge, 2007) . In addition, NAC supplementation appears to ameliorate many elements involved in the pathophysiology of ARDS. For example, NAC supplementation decreases neutrophil recruitment and activity while increasing neutrophil apoptosis in an environment of intense J o u r n a l P r e -p r o o f lung inflammation (Backer et al. , 1996 , Hasan et al. , 2016 , Moon et al. , 2010 , Paranjape, 2006 , Urban et al. , 1997 . The increased levels of neutrophil apoptosis seen following NAC administration appears to be due to increased efferocytosis of AMs which appears to be secondary to improved redox status (Failli et al. , 2002 , Moon et al., 2010 . In addition, evidence suggests that NAC also reduces levels of platelet, monocyte and neutrophil complexes in vivo (Craver et al. , 2020 , Treweeke et al. , 2012 . Furthermore, several studies have reported that NAC supplementation results in a reduction in neutrophil production of NETs (Al-Khafaji et al. , 2016 , Craver et al., 2020 , Kirchner et al. , 2013 .

Evidence from human studies also suggests that NAC reduces levels of platelet monocyte and neutrophil complexes in vivo (Craver et al., 2020 , Treweeke et al., 2012 . Several authors have also reported significant reductions in levels of pulmonary inflammation following NAC supplementation at approximately 1200 mg/day as evidenced by reduced levels of PICs, ROS, tissue damage and fibrin deposits in alveoli and interstitial tissue (Hagiwara et al. , 2000 , Lai et al. , 2010 . There is also evidence to suggest that NAC improves pulmonary function, an effect which appears to be enhanced when the thiol is inhaled (Feng et al., 2019 , Li et al. , 2018 . NAC supplementation also exerts several other anti-inflammatory effects relevant to the pathophysiology of ARDS, most notably by decreasing levels of IL-6 (Nascimento et al. , 2010 , Nizomov, 2015 , Saddadi et al. , 2014 and NF-κB (Farid et al. , 2005 , Paterson et al. , 2003 , Wu et al. , 2014 .

Finally, authors of a prospective double blind RCT investigating the use of 1200mg/day in mechanically ventilated patients reported, that compared to placebo, patients administered NAC were less likely to develop ventilator associated pneumonia (VAP), had a significantly reduced stay in intensive care unit and an increased incidence of complete recovery J o u r n a l P r e -p r o o f (Sharafkhah et al. , 2018) . This may be of significance from the perspective of treating COVID-19 ARDS as VAP may well be a significant cause of long term morbidity and mortality in patients requiring mechanical ventilation despite improvements made by prone positioning (Ayzac et al. , 2016) .

Several research teams have reported reduced endothelial cell activation and improved endothelial function following supplementation with oral NAC (Martina et al. , 2008 , Masha et al. , 2009 , Pieper and Siebeneich, 1998 . Interestingly, the mechanism appears to involve inhibition of the NLRP3 inflammasome (Kudaravalli, 2011 , Molnar et al. , 2003 , Zuin et al. , 2005 . In addition significant inhibition of platelet activity has been reported in in patients with type 2 diabetes and in healthy volunteers (Anfossi et al. , 2003 , Gibson et al. , 2009 , Gibson et al. , 2011 , Wang et al. , 2018a , which appears to be secondary to increased levels of intraplatelet glutathione and production of NO with a concomitant reduction in levels of oxidative stress (Wang et al., 2018a) .

In addition, evidence suggests that NAC inhibits the development of large vessel thrombosis in inflammatory illnesses such as diabetes (Wang et al., 2018a) and may even reduce thrombus formation to a similar degree to the effect produced by low dose aspirin (Craver et al., 2020) . Intravenous NAC administration promotes lysis of arterial thrombi in patients who are resistant to antiplatelet thrombin inhibitors and recombinant tissue-type plasminogen activator targeting VWF (Chen et al. , 2011 , Martinez de Lizarrondo et al. , 2017 . Such data has increased interest in the use NAC in patients displaying evidence of aspirin resistance despite being prescribed a dose known to inhibit thromboxane A2 (DiNicolantonio et al. , 2017 , Kreil et al. , 1990 .

It is important to stress that the anticoagulant and platelet-inhibiting properties of NAC are seen in in patients with serious conditions such as those undergoing major vascular surgery (Niemi et al. , 2006) . It is also noteworthy that the anticoagulant effects of NAC extend to decreasing the activity of coagulation factors II, VII and X, thereby producing a significant decrease in prothrombin time (Jepsen and Hansen, 1994, Thorsen et al. , 2009 ). These properties have led to an increased focus on an expanded role of NAC in the inhibition of platelet aggregation in the context of reperfusion injury in recent years (reviewed by (Nikbakht et al. , 2017) ). Some of the mechanisms underpinning the effects of NAC on the coagulation and fibrinolytic systems ultimately leading to decreased thrombus formation have been discussed above. However a reader interested in an in depth consideration of the area are referred to an excellent review by (Gutmann et al. , 2020) .

The weight of evidence suggests that severe vitamin (Vit) D deficiency is a common occurrence in intensive care unit (ICU) patients with sepsis, septic shock and ARDS (Kempker et al. , 2012 , Nair et al. , 2018 . In addition, several authors have reported positive correlations between Vit D levels and increasing illness severity (Kempker et al., 2012 , Nair et al., 2018 , Takeuti et al. , 2018 . The extent of Vit D depletion also appears to be predictive of increased mortality reviewed (Williams and Heuberger, 2016) . It is also noteworthy that the level of Vit D depletion on admission to hospital is also predictive of developing severe disease and poor outcomes (Bjelakovic et al. , 2014 , Shojaei et al. , 2019 .

The relationship between low Vit D levels and increased severity of sepsis, appears to be due, at least in part, to exaggerated levels of inflammation and immune activation compared to patients with adequate levels of this vitamin (Lucas et al. , 2014 , Manion et al. , 2017 , Shepherd et al. , 2014 . This phenomenon may well exist in other illnesses whose J o u r n a l P r e -p r o o f pathophysiology involves chronic systemic immune activation and inflammation (Lucas et al., 2014 , Manion et al., 2017 , Shepherd et al., 2014 . In fact several human studies investigating Vit D levels in conditions such as type 2 diabetes and metabolic syndrome have reported higher activity of NF-κB and increased levels of PICs in patients with Vit D deficiency compared to those whose level of the vitamin is within normal limits (Bergholm et al. , 2002 , Csiszar et al. , 2008 , Goncalves-Mendes et al. , 2019 , Ni et al. , 2014 . These findings are consistent with other lines of evidence suggesting that Vit D plays an indispensable role in modulating inflammation and adequate levels are needed for an optimal anti-inflammatory response to prevent an over exuberant immune response to invading pathogens or sterile insults (Giulietti et al. , 2007 , Holick, 2007 , Zhang et al. , 2012 .

Unsurprisingly Vit D exerts a wide range of broadly tolerogenic effects on the immune response via engagement with the Vit D receptor and these are summarised in Figure 2 .

Several human studies confirming a beneficial effect of Vit D on NF-κB activity and levels of PICs most notably TNF-alpha and IL-6 (Bergholm et al., 2002 , Csiszar et al., 2008 , Goncalves-Mendes et al., 2019 , Ni et al., 2014 reviewed. It is also noteworthy that a recent double blind RCT. Ventilated patients using a dose of Vit D in the range of 250,000 to 500,000 IU (55 ng/ml) over 7 days reported clinically significant reductions hospital stay suggesting that the dose needed to treat COVID-19 ARDS is likely to be of the same order (Han et al. , 2016) .The issue of dosage as also addressed in a recent meta-analysis investigating the use of Vit D in the treatment or prophylaxis of respiratory virus infections which reported significant benefit at levels greater than 40ng/ml but no evidence of benefit at lower doses (Martineau et al. , 2017) reviewed (Grant et al. , 2020) . There is some evidence that Vit D supplementation may improve the immune status in patients with HIV J o u r n a l P r e -p r o o f (Alvarez et al., 2019) dengue (Fatima et al. , 2018) and hepatitis B infections (Hu et al. , 2019) .

There is evidence that Vit D supplementation may decrease the replication of rhinoviruses via a mechanism involving the upregulation of the interferon response and cathelicidin (LL-37) in lung epithelial cells (Schögler et al. , 2016 , Telcian et al. , 2017 . LL-37 upregulation appears to be a major element involved in the anti-viral defences of lung epithelial cells and this also appears to be true of macrophages and dendritic cells. Importantly, there is also evidence to suggest that LL-37 upregulation may inhibit the replication of herpes simplex virus type one (HSV-1), respiratory syncytial virus (RSV) vaccinia virus HIV and HTLV-1, H1N1

and Ebola (Beard et al. , 2011 , Harcourt et al. , 2016 , Hsieh and Hartshorn, 2016 , Yu et al. , 2020 . Unsurprisingly, given the information above depleted levels of Vit D are associated with sub optimal LL-37 expression in lung epithelial cells which are a known target for SARS-CoV-2 entry (Beard et al., 2011) . Hence when considered as a whole this data combined with the multiple lines of evidence discussed above support the use of Vit D as part of a rational treatment approach for COVID-19. Finally, Vit D acts in alliance with many other molecules and systems when exerting its effects on the immune response and hence potential synergies may exist when combined with other molecular players such as melatonin reviewed (Martín Giménez et al. , 2020) . Readers interested in a detailed consideration of the role of LL-37 in the pulmonary immune response to infection are referred to the work of (Tecle et al. , 2010) .

Levels of Vit C, otherwise known as ascorbic acid, are grossly depleted in many patients with severe infections sepsis and septic shock despite being administered adequate levels of J o u r n a l P r e -p r o o f enteral or parenteral nutritional therapy (Ang et al. , 2018 , Kuhn et al. , 2018 , Marik, 2018 . Mechanistically this state of affairs appears to be due to increased consumption due to high levels of oxidative stress (Ang et al., 2018 , Kuhn et al., 2018 and the inhibitory effect of PICs on the sodium dependent Vit C transporter (SVCT) 2 (Fowler et al. , 2014 , Oudemans-van Straaten et al. , 2014 . This receptor is expressed in most cells and responsible for the cellular entry of ascorbate (Fowler et al., 2014 , Oudemans-van Straaten et al., 2014 . Readers interested in a more detailed consideration of this topic are invited to consult a thorough review of the area in (Mangin et al. , 2014) .

Ascorbate related hypovitaminosis is associated with increased levels of inflammation and compromised immune function in a similar manner to the scenario of severe Vit D depletion (Carr and Maggini, 2017 , Sánchez-Moreno et al. , 2004 , Traber et al. , 2019 . Higher levels of inflammation increased activity of NF-κB increased production of NETs and increased neutrophil netosis (Bozonet and Carr, 2019, Mohammed et al. , 2013) . Vit C exerts a range of anti-inflammatory effects on the immune system via the modulation of hypoxia inducible factor alpha (HIFalpha) levels and levels of histone acetylation and DNA methylation via regulating the activity of ten eleven translocase (TET) and proteins containing a Jumonyi C (JDHM) domain (Ang et al., 2018 , Boretti and Banik, 2020 , Fenech et al. , 2019 . A summary of the phenotypic changes in the immune response induced by the activity of Vit C and the mechanisms involved is included in Figure 3 .

The bioavailability of oral form of Vit C are limited by the activity of SVCT1 which appears to reach saturation level in the dose range of 500-1000mg limiting plasma levels to approximately 220 micromoles/ml. However, the use of IV administration bypasses the limitations of this receptors leading to plasma levels of Vit C which are some 70 times higher J o u r n a l P r e -p r o o f at 15,000 micromoles/ml (Levine et al. , 1996 , Padayatty et al. , 2004 suggesting that the IV formulation would be the one of choice in any intervention aiming to treat COVID-19. This point is reinforced by data supplied by the citrus study reporting that IV Vit C administration at 200 mg/kg 4 days resulted in significant reduction in hospital stay and overall mortality in ventilated ARDS patients (Fowler et al. , 2019) . In addition the oral doses of Vit C needed to produce evidence of therapeutic benefit in this patient group would appear to be in excess of 6g/day although at these doses data suggests that ventilation time in ARDS patients may be reduced by 25% review (Hemilä and Chalker, 2020) . In addition, there is growing interest in combining Vit C, thiamine and hydrocortisone as a treatment for sepsis and ARDS following the results of a recent study where the use of these preparations in unison resulted in a 25% reduction in mortality (Marik et al. , 2017) .

Finally, there is evidence to suggest that high dose IV Vit C inhibits the replication of rhinoviruses (Hemilä and Herman, 1995) , H1N1 (Cai et al. , 2015) , Chikungunya (Gonzalez et al. , 2016) , Zika (J. González et al. , 2016) and seasonal influenza (Zarubaev et al. , 2017) . In addition there is also some evidence that oral supplementation with Vit C (doses over 3g) may also reduce the risk of infection by prevent respiratory viruses (Carr and Maggini, 2017) .

Dexamethasone exerts its anti-inflammatory effects by upregulating the activity of glucocorticoid receptors (GR) and inhibiting the activity of a number of proinflammatory transcription factors including NF-κB reviewed .This is an important point as the weight of histopathological evidence suggests that non resolving ARDS is associated with increased activity of nuclear NF-κB and decreased activity of nuclear GRs J o u r n a l P r e -p r o o f (Schwingshackl and Meduri, 2016, Umberto Meduri et al. , 2011) . In the light of this data and the potential decrease in mortality in patients suffering from COVID-19 ARDS following dexamethasone administration and its mechanism of action is briefly considered below.

Following diffusion across the cell membrane dexamethasone and indeed other glucocorticoids bind to the cytosolic GR resulting in a conformational change freeing the GR from the constraints of a heat shock chaperone (Revollo and Cidlowski, 2009 ). The unencumbered GR then translocate to the nucleus and bind to glucocorticoid-responsive elements (GREs) located in the promoter regions of proinflammatory and anti-inflammatory genes increasing the transcription of the latter and decreasing the transcription of the former by cis-activation or cis-repression respectively (Baschant and Tuckermann, 2010, Liberman et al. , 2018) . These mechanisms are reviewed in (Xavier et al. , 2016) . GRs may also engage with other transcription factors in the nucleus limiting or modifying their DNA binding activity by various mechanisms such as competing for the same indispensable cofactor and may also act posttranscriptional by modifying the stability of mRNA (Liberman et al., 2018) (reviewed in (Laryea et al. , 2015) ).

Dexamethasone upregulated GR activity mediates NF-κB inhibition by increasing the production and inhibiting the degradation IκBα which sequesters NF-κB in the cytoplasm via direct effects on the GRE sequence in the IκBα gene and in the gene responsible for the production of IL-10. The use of dexamethasone also results in the formation of GR-NF-κB complexes in the nucleus resulting in the reduced activity of NF-κB due to restricted access to the indispensable cofactors steroid receptor coactivator-1 (SRC-1) and CREB-binding protein (CBP). Several authors have also reported increased expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in lung epithelial cells following dexamethasone J o u r n a l P r e -p r o o f administration at physiological concentrations (Jang et al. , 2007 , King et al. , 2009 This has the effect of decreasing the activity of MAP kinase which plays an indispensable role in IL-1 and TNF-alpha mediated increases in the activity of NF-κB (Jang et al., 2007 , King et al., 2009 ).This data is of particular interest as this may be an effect which is unique to this steroid and may underpin significant depression in pulmonary IL-8 levels following its administration (Dauletbaev et al. , 2011 , Shah et al. , 2013 . Finally, there is also evidence to suggest that dexamethasone ligated GRs form complexes with p65 NF-κB subunits in the cytoplasm which ultimately translocate to the nucleus exhibiting greater anti-inflammatory activity and inducing increased production of anti-inflammatory proteins such as A20 compared to GR receptors acting alone (Altonsy et al. , 2014 , Kadiyala et al. , 2016 .

Dexamethasone may have value in COVD-19 characterised by a cytokine storm.

Dexamethasone has potent anti-inflammatory effects that are dose related. It inhibits LPSstimulated ΤΝF-alpha release, as well as levels of IL-6, IL-8 and of IL-10 (Giamarellos- Bourboulis et al. , 2020) . In bacterial community acquired pneumonia, dexamethasone compared to placebo significantly lowered levels of f IL-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and TNF-alpha (Remmelts et al. , 2012) . Timing appears to be a critical factor, as corticosteroids may have value in severe SARS-CoV-2 infection characterised by the presence of the hyperinflammation phase of a cytokine storm (Ye et al., 2020) . In early and milder disease, viral clearance can be delayed and inhibited, resulting in poorer outcomes. Evidence of this derives from the SARS experience, where a 20.7-fold higher risk of ICU admission was seen with the routine use of steroids (Auyeung et al. , 2005) . Similarly, during the middle east respiratory syndrome (MERS) epidemic, corticosteroid therapy worsened outcomes due to delayed clearance of MERS coronavirus (Arabi et al. , 2018) . The extant data from the COVID-19 pandemic suggests that use of steroids in non-critical J o u r n a l P r e -p r o o f patients without a cytokine storm is not advisable (Russell et al. , 2020) . Dexamethasone may have benefit in ventilator induced lung injury (Hegeman et al. , 2011) . There are case reports of the use of dexamethasone in the treatment of SARS-CoV-2 pneumonia complicated by pulmonary oedema resulting from the pulmonary capillary leak syndrome (Bahloul et al. , 2020) . Preliminary non-peer reviewed data from the Randomised Evaluation of COVID-19 (RECOVERY) trial suggests a benefit in people with severe COVID-19 infection on ventilators in ICU (2020) .

A comprehensive and highly plausible model has been proposed in this paper detailing the pathophysiological steps of COVID-19 from the point of initial infection of type II alveolar epithelial cells by SARS-CoV-2 to the ultimate development of ARDS. This model highlights are various several potential control points where targeted therapeutic interventions might produce significant benefits in reducing the severity of disease. Several lines of evidence suggest a role for dexamethasone for the treatment of ARDS. In addition, consideration of data supplied by human an animal studies also highlight the potential efficacy of Zn supplementation, aspirin (acetylsalicylic acid), the macrolide antibiotic azithromycin, oral or intravenous administration of NAC, IV Vit C and oral Vit D. Moreover, when used at appropriate doses, these supplements and drugs generally have an exceptionally good safety record. Hence, based on this evidence, it is recommended that randomised trials of these therapeutic substances in COVID-19 are in order. Given that excessive levels systemic inflammation seen in patients with severe COVID-19 is likely to lead to depleted levels of Vit C, Vit D and Zn in many individuals and significant differences in their mode of action as antiinflammatory agents, it is suggested that they should be used in combination. Equally, the use of aspirin at a dose in excess of 300 mg, NAC and AZM offers the prospect of localised 

GM conceptualized the work and was a major contributor in writing the manuscript. CCB created the figures. All authors have drafted part and approved the final manuscript.

Biggest COVID-19 trial tests repurposed drugs first

Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Azithromycin Suppresses Activation of Nuclear Factor-kappa B and Synthesis of Pro-inflammatory Cytokines in Tracheal Aspirate Cells From Premature Infants

Superoxide induces Neutrophil Extracellular Trap Formation in a TLR-4 and NOX-dependent mechanism

Zinc and Sepsis

Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics

Context-dependent cooperation between NF-kB and the glucocorticoid receptor at a TNFAIP3 enhancer: a mechanism to maintain negative feedback control of inflammation

The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection

Platelet resistance to the antiaggregating effect of N-acetyl-l-cysteine in obese, insulin-resistant subjects

Vitamin C and immune cell function in inflammation and cancer

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

Platelets in Sepsis: An Update on Experimental Models and Clinical Data

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study

The Multiple Faces of the Metal Transporter ZIP14 (SLC39A14). The Journal of nutrition

N-Acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid

Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection

Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt

Vitamin D and the anti-viral state

Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome

Impaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid Arthritis. Arteriosclerosis, thrombosis, and vascular biology

A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. The American journal of clinical nutrition

Vitamin D supplementation for prevention of mortality in adults. The Cochrane database of systematic reviews

Aspirin therapy inhibits NLRP1 (nucleotide-binding Vasc Surg

Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial

Extracellular traps and macrophages: new roles for the versatile phagocyte

Intravenous Vitamin C for reduction of cytokines storm in Acute Respiratory Distress Syndrome

Zinc deficiency primes the lung for ventilator-induced injury

The Role of Physiological Vitamin C Concentrations on Key Functions of Neutrophils Isolated from Healthy Individuals

The role of neutrophil death in chronic inflammation and cancer. Cell death discovery

A new mechanism of vitamin C effects on A/FM/1/47(H1N1) virus-induced pneumonia in restraint-stressed mice

Platelet activation is associated with myocardial infarction in patients with pneumonia

Vitamin C and Immune Function

Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes

Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy

Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis

Lipoxins: nature's way to resolve inflammation

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins, leukotrienes, and essential fatty acids

Aspirin triggers antiinflammatory 15-epilipoxin A4 and inhibits thromboxane in a randomized human trial

Granulocyte macrophage-colony stimulating factor (GM-CSF) augments acute lung injury via its neutrophil priming effects

Zinc and selenium status in critically ill patients according to severity stratification

Oxygenated lipid signaling in tumor-associated macrophagesfocus on colon cancer

Long-term treatment with oral Nacetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial

Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection

Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis

The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release

N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm

Long-term macrolide therapy in chronic inflammatory airway diseases

The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1

Inflammation and endothelial dysfunction during aging: role of NF-kappaB

The NLRP3 Inflammasome and Its Role in Sepsis Development

Down-regulation of Cytokine-induced Interleukin-8 Requires Inhibition of p38 Mitogen-activated Protein Kinase (MAPK) via MAPK Phosphatase 1-dependent and -independent Mechanisms

Aspirin-Dependent Platelet Inflammatory Inhibition in Healthy Subjects Decreases NLRP-1 Inflammasome. Annals of vascular surgery

SARS and MERS: recent insights into emerging coronaviruses

The role for N-acetylcysteine in the management of COPD

Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients? Annals of intensive care

Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality

Inflammasomeregulated cytokines are critical mediators of acute lung injury

Antiplatelet Therapy for Critically Ill Patients: A Pairwise and Bayesian Network Meta-Analysis

Targeting granulocyte apoptosis: mechanisms, models, and therapies

Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial

Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats

Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2

Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses

Thrombosis as an intravascular effector of innate immunity

Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury

Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis

Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin

Regulation of alveolar macrophage death in acute lung inflammation

Zinc inhibits high glucose-induced NLRP3 inflammasome activation in human peritoneal mesothelial cells

Effects of dietary curcumin or N-acetylcysteine on NF-κB activity and contractile performance in ambulatory and unloaded murine soleus

Macrophage Clearance of Neutrophil Extracellular Traps Is a Silent Process

Dengue viral infection deteriorates vitamin D3, K, thrombopoietin, and angiotensinogen levels in humans

Collateral damage: necroptosis in the development of lung injury

Long-term macrolides in diffuse interstitial lung diseases

Vitamin C Content in Fruits: Biosynthesis and Regulation

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis

Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas

Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial

Vander Heide RS. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans

Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation

Oxidative stress and platelets. Arteriosclerosis, thrombosis, and vascular biology

HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death

Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock

The role of zinc lozenges in treatment of the common cold. The Annals of pharmacotherapy

COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Medicine

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity

Therapeutic potential of Nacetylcysteine as an antiplatelet agent in patients with type-2 diabetes

Monocytes from type 2 diabetic patients have a pro-inflammatory profile. Diabetes research and clinical practice

Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial

High Dose Intravenous Vitamin C Treatment for Zika Fever

Critical role for the NLRP3 inflammasome during acute lung injury

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials

Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits

Clearance of apoptotic neutrophils and resolution of inflammation

Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation

Reactive Oxygen Species in Venous Thrombosis

Aerosolized Administration ofN-Acetylcysteine Attenuates Lung Fibrosis Induced by Bleomycin in Mice

High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial

The acute respiratory distress syndrome: from mechanism to translation

Inhibition of HIV-1 infection by zinc group metal compounds

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells

N-acetyl-L-cysteine and cysteine increase intracellular calcium concentration in human neutrophils

Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways

Temporal dynamics in viral shedding and transmissibility of COVID-19

Liposomeencapsulated dexamethasone attenuates ventilator-induced lung inflammation

Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage

Zinc lozenges may shorten the duration of colds: a systematic review

The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis

Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis

Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial

Vitamin C and the common cold: a retrospective analysis of Chalmers' review

Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis

Identification of a Conserved RNA-dependent RNA Polymerase (RdRp)-RNA Interface Required for Flaviviral Replication

Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages

Azithromycin Improves Macrophage Phagocytic Function and Expression of Mannose Receptor in Chronic Obstructive Pulmonary Disease

Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin chronic obstructive pulmonary disease subjects

Apoptosis and caspases regulate death and inflammation in sepsis

NLRP3/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1 secretion in acute lung injury induced by cardiopulmonary bypass

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy

Low vitamin D levels are associated with high viral loads in patients with chronic hepatitis B: a systematic review and meta-analysis

The Role of Macrophages in the Pathogenesis of ALI/ARDS

Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis

Azithromycin therapy for neutrophilic airways disease: myth or magic?

Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages

PAMPs and DAMPs as triggers for DIC

High dose intravenous vitamin c treatment in a patient with lung cancer: A case report

N-acetyl-l-cysteine attenuates thrombin-induced increases of pulmonary and airway pressures and lung lymph flow in anesthetized sheep

Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists

Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin

Vitamin C in sepsis

High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia

Dissection of Glucocorticoid Receptor-mediated Inhibition of the Hypothalamic-pituitary-adrenal Axis by Gene Targeting in Mice

Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury

Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice

Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation

Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance

N-Acetylcysteine inhalation improves pulmonary function in patients received liver transplantation

Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway

The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing

Interleukin-1beta contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes

Hemostatic abnormalities in sickle cell disease

Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV

Zinc regulates the acute phase response and serum amyloid A production in response to sepsis through JAK-STAT3 signaling

Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis

Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response

Immunologic effect of zinc supplementation in HIV-infected children receiving highly active antiretroviral therapy: a randomized, double-blind, placebo-controlled trial

ROS-induced NLRP3 inflammasome priming and activation mediate PCB 118-induced pyroptosis in endothelial cells

Evaluation of inflammatory cytokine secretion by human alveolar macrophages

N-acetylcysteine for adults with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials

Unfractionated Heparin Alleviates Human Lung Endothelial Barrier Dysfunction Induced by High Mobility Group Box 1 Through Regulation of P38-GSK3β-Snail Signaling Pathway

The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue

Vitamin D and immunity. F1000prime reports

Azithromycin inhibits neutrophil accumulation in airways by affecting interleukin-17 downstream signals

Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent

Interleukin-18 levels reflect the long-term prognosis of acute lung injury and acute respiratory distress syndrome

Inflammation and vitamin D: the infection connection. Inflammation research : official journal of the European Histamine Research Society

Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons

Vitamin C for the treatment of sepsis: The scientific rationale

Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock

Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment

Long-Term N-Acetylcysteine and L-Arginine Administration Reduces Endothelial Activation and Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus

Pathogenesis of COVID-19 from a cell biologic perspective

Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colonystimulating factor during the course of acute respiratory distress syndrome

TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms

Monocyte-derived Alveolar Macrophages: The Dark Side of Lung Repair? American journal of respiratory cell and molecular biology

COVID-19: consider cytokine storm syndromes and immunosuppression

Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days later

Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha

Possible activation of NRF2 by Vitamin E/Curcumin against altered thyroid hormone induced oxidative stress via NFkB/AKT/mTOR/KEAP1 signalling in rat heart

Vitamin C: a novel regulator of neutrophil extracellular trap formation

Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, doubleblinded, placebo-controlled clinical trial

N-Acetylcysteine Inhibits RhoA and Promotes Apoptotic Cell Clearance during Intense Lung Inflammation

Cytokine release syndrome in severe COVID-19

Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations

Effects of low-dose aspirin on acute inflammatory responses in humans

Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia

Azithromycin alters macrophage phenotype

Vitamin D status and supplementation in adult patients receiving extracorporeal membrane oxygenation

Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia

Inflammation Is a Necessary Evil

Necroptosis and Inflammation

Elimination of vitamin D receptor in vascular endothelial cells alters vascular function

The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm

The Role of N-Acetylcysteine in Platelet Aggregation and Reperfusion Injury in Recent Years

Effect of N-acetylcysteine indicators of proinflammatory cytokines in patients with acute coronary syndrome with st segment elevation

N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention

Oligomerized, filamentous surface presentation of RANTES/CCL5 on

Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use

Faculty Opinions recommendation of High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Faculty Opinions -Post-Publication Peer Review of the Biomedical Literature: Faculty Opinions Ltd

Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment

The effect of N-acetylcysteine on nuclear factor-κB activation interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis*

The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin

Mineral particles stimulate innate immunity through neutrophil extracellular traps containing HMGB1

Biological basis and pathological relevance of microvascular thrombosis

Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: A preliminary report

Oral Administration of the Antioxidant, N-Acetylcysteine, Abrogates Diabetes-Induced Endothelial Dysfunction

The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3

LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. European review for medical and pharmacological sciences

Efficacy of Ascorbic Acid (Vitamin C) and/N-Acetylcysteine (NAC) Supplementation on Nutritional and Antioxidant Status of Male Chronic Obstructive Pulmonary Disease (COPD) Patients

Quantum Transition in Zinc Atoms of Flavavirus Polymerase Triggers the Conformation of the Polymerase Motif F. bioRxiv

Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury

Zinc: mechanisms of host defense

Lipopolysaccharideinduced lung inflammation is inhibited by neutralization of GM-CSF

Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases

High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review

Prescribing for people with acute rheumatic fever

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome

Dexamethasone downregulates the systemic cytokine response in patients with communityacquired pneumonia

Mechanisms generating diversity in glucocorticoid receptor signaling

Lipoxins and aspirin-triggered lipoxins in resolution of inflammation

Epidemiology and outcomes of acute lung injury

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Dysregulation of lung myeloid cells in COVID-19

Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke

N-acetylcysteine in COPD: why, how, and when?

Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury

Cell Death in the Lung: The Apoptosis-Necroptosis Axis

High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells

Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37

In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay

Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us

Inhibition of inflammatory gene expression by dexamethasone partly depends on the phosphatase, MKP-1 (DUSP1)

Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock

Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial. Med Gas Res2018

Macrophage Rewiring by Nutrient Associated PI3K Dependent Pathways

Effect of High/Low Dose N-Acetylcysteine on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis

Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected Persons

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

COVID-19 infection: the perspectives on immune responses

Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells

Macrolides and airway inflammation in children

The Correlation between Serum Level of Vitamin D and Outcome of Sepsis Patients; a Cross-Sectional Study

Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation

Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes

Zinc for the common cold. The Cochrane database of systematic reviews

Role of platelets in immune system and inflammation

Mechanistic insights into the protective impact of zinc on sepsis

Neutrophils scan for activated platelets to initiate inflammation

Platelet-neutrophil crosstalk and netosis

Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Effect of zinc salts on respiratory syncytial virus replication

Zinc depletion regulates the processing and secretion of IL-1β

Role of long term antibiotics in chronic respiratory diseases

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C

Applications of vitamin D in sepsis prevention

Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

Review: Defensins and cathelicidins in lung immunity

High-Dose Aspirin Is

Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro

Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

High-dose oral Nacetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome

The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome

Selective depletion of alveolar macrophages in polymicrobial sepsis increases lung injury, bacterial load and mortality but does not affect cytokine release

N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial

Azithromycin Blocks Neutrophil Recruitment inPseudomonasEndobronchial Infection

Contributions of high mobility group box protein in experimental and clinical acute lung injury

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment

Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid

Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions

Neutrophil function and glutathione-peroxidase (GSHpx) activity in healthy individuals after treatment with N-acetyl-L-cysteine

Macrolides Inhibit IL17-induced IL8 and 8-isoprostane Release from Human Airway Smooth Muscle Cells

Endothelial cell infection and endotheliitis in COVID-19

Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans Syndrome

Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nutrition, supplements, and vitamins in platelet function and bleeding

Macrolide antibiotics and survival in patients with acute lung injury

Necroptosis regulated proteins expression is an early prognostic biomarker in patient with sepsis: a prospective observational study

N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes

Aveolar Macrophage Activation and Cytokine Storm in the Pathogenesis of Severe COVID-19

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

The laboratory tests and host immunity of COVID-19 patients with different severity of illness

Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway

Effects of aspirin on the expression of nuclear factor-κB in a rat model of acute pulmonary embolism

Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis

Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis

Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell Sequencing

Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation

Outcomes of Vitamin D Supplementation in Adults Who are Deficient and Critically Ill: A Review of the Literature

Antiplatelet drugs and outcome in mixed admissions to an intensive care unit*

Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms

Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome

Inhibition of Alveolar Macrophage Pyroptosis Reduces Lipopolysaccharide-induced Acute Lung Injury in Mice

Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19

N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and cardiomyocyte apoptosis in heart failure

Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses

Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury

PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease

Platelets in the pathogenesis of acute respiratory distress syndrome. American journal of physiology Lung cellular and molecular physiology

Macrolide Treatment Decreased the Size of Nasal Polyps and IL-8 levels in Nasal Lavage

Macrolides Inhibit Epithelial Cell-Mediated Neutrophil Survival by Modulating Granulocyte Macrophage Colony-Stimulating Factor Release. American journal of respiratory cell and molecular biology

New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome

Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection

Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. The Journal of infection

Downregulation of TNF-α/ NF-R1 Signals by AT-Lipoxin A4 May Be a Significant Mechanism of Attenuation in SAP-Associated Lung Injury

Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection. iScience

Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review. Tropical medicine & international health

The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome

N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial

COVID-19: Melatonin as a potential adjuvant treatment

Dying as a Pathway to Death in Sepsis

Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis

Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1

Lipoxin A(4) promotes lung epithelial repair whilst inhibiting fibroblast proliferation

Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression

The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms

High-Dose N-Acetylcysteine in??Patients with Exacerbations of??Chronic Obstructive Pulmonary Disease

Neutrophil extracellular traps in COVID-19. JCI Insight

Figures were created with BioRender.com